Related Articles
Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients
Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers
Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR‑TKIs
EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature
Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma